Fortrea Holdings FTRE
NASDAQ FTRE
$18.27 -0.35 (-1.85%)
As of: Sep 4, 2026 · 11:50 AM EDT

Fortrea Holdings (FTRE) Other Non Operating Income (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Other Non Operating Income came in at $3.5 million in Q2 2026, up 117.59% YoY from $1.6 million in Q2 2025, and down 63.92% on a QoQ basis from $9.7 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Other Non Operating Income (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has 5 years of Other Non Operating Income data on file, last reported at $3.5 million in Q2 2026.

  • Quarterly Other Non Operating Income rose 117.59% year-over-year to $3.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $19.5 million (up 234.48% YoY) and the FY2025 annual result came in at -$26.9 million, down 226.29% from the prior year.
  • Other Non Operating Income slipped to $3.5 million in Q2 2026, from $9.7 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $12.0 million in Q2 2022 to a low of -$19.9 million in Q2 2025.
  • A 5-year average of $729411.8 and a median of $3.6 million in 2023 frame the typical range for Other Non Operating Income.
  • Annual changes were most pronounced in 2025 — Other Non Operating Income tumbled 321.11% — and 2026, when it jumped 273.21%.
  • Tracing FTRE's Other Non Operating Income over 5 years: stood at -$19.0 million in 2022, then jumped by 112.11% to $2.3 million in 2023, then jumped by 169.57% to $6.2 million in 2024, then slumped by 80.65% to $1.2 million in 2025, then surged by 191.67% to $3.5 million in 2026.
  • The last three Other Non Operating Income figures came in at $3.5 million (Q2 2026), $9.7 million (Q1 2026), and $1.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 140.22 Bn 132.37 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.04 Bn 78.05 Bn 3.93 Bn
3 Argenx Se 63.70 Bn 58.52 Bn 1.37 Bn
4 Moderna 57.56 Bn 52.42 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 40.16 Bn 35.06 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.63 Bn 32.32 Bn 992.69 Mn
8 Royalty Pharma 28.63 Bn 27.79 Bn -
9 Insmed 27.73 Bn 26.57 Bn 358.27 Mn
10 Fortrea Holdings 1.73 Bn 1.56 Bn 139.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.50 Mn
Mar 31, 2026 9.70 Mn
Dec 31, 2025 1.20 Mn
Sep 30, 2025 5.10 Mn
Jun 30, 2025 -19.90 Mn
Mar 31, 2025 -5.60 Mn
Dec 31, 2024 6.20 Mn
Sep 30, 2024 4.80 Mn
Jun 30, 2024 9.00 Mn
Mar 31, 2024 -5.30 Mn
Dec 31, 2023 2.30 Mn
Sep 30, 2023 3.60 Mn
Dec 31, 2022 -19.00 Mn
Sep 30, 2022 4.80 Mn
Jun 30, 2022 12.00 Mn